« Shire Expands its Human Genetic Therapies Pipeline Through In ... - CNNMoney.com | Main | Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder »

November 11, 2007

Commercial Insight: Antihypertensives - Two Years to Shape the Market?

Introduction
Datamonitor expects the antihypertensive market to exceed 0bn by 2014 across the seven major markets, with novel treatments and the market-leading ARBs delivering much of this value. However, significant hurdles exist, and pharma...

Additionnal resources regarding this market :

Commercial Insight: Antihypertensives - Two Years to Shape the Market?

Posted at 11:14 AM |

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e54ed2f120883300e54f93f1848834

Listed below are links to weblogs that reference Commercial Insight: Antihypertensives - Two Years to Shape the Market?:

Comments

Verify your Comment

Previewing your Comment

Posted by:  | 

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been posted. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment